CD79A and infection: In summary, we have investigated the kinetics and differences in IgG and IgA antibody responses to the S1, S2, RBD, and N in those with varying severity of infection and vaccines who received a single dose of AZD1222, which showed that vaccines had significantly less IgA to SARS-CoV-2, but comparable IgG responses those with natural infection.